HAP Trading’s Inovio Pharmaceuticals INO Stock Holding History

HAP Trading’s Portfolio INO Stock Details INO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-2,915	Closed	-$234K	–	2683
2021 Q3	$250K	Buy	+2,915	New	+$293K	0.01%	951
2021 Q2	–	Sell	-1,805	Closed	-$173K	–	2520
2021 Q1	$201K	Buy	+1,805	New	+$237K	0.01%	770

Other funds holding INO

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

HAP Trading's INO Position: Q4 2021 in Review

HAP Trading sold out of Inovio Pharmaceuticals (INO) in Q4 2021, closing a stake of 2,915 shares — an estimated $234K sold.

HAP Trading first reported a position in INO in Q1 2021 and held it in 2 quarters. The position peaked at $250K in Q3 2021. 208 funds tracked by Wall St. Rank hold INO as of Q4 2021.

HAP Trading reported no remaining Inovio Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
HAP Trading sold 2,915 Inovio Pharmaceuticals shares in Q4 2021, an estimated $234K.
HAP Trading first reported a position in Inovio Pharmaceuticals in Q1 2021 and held it in 2 quarters.
HAP Trading's Inovio Pharmaceuticals position peaked at $250K in Q3 2021.
208 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q4 2021.

Based on HAP Trading's 13F filing for Q4 2021, filed 14 Feb 2022.